CA2002106A1 - Derives o-acyles du 1,5-dideoxy-1, 5-imino-d-glucitol - Google Patents

Derives o-acyles du 1,5-dideoxy-1, 5-imino-d-glucitol

Info

Publication number
CA2002106A1
CA2002106A1 CA2002106A CA2002106A CA2002106A1 CA 2002106 A1 CA2002106 A1 CA 2002106A1 CA 2002106 A CA2002106 A CA 2002106A CA 2002106 A CA2002106 A CA 2002106A CA 2002106 A1 CA2002106 A1 CA 2002106A1
Authority
CA
Canada
Prior art keywords
glucitol
dideoxy
imino
carbon atoms
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2002106A
Other languages
English (en)
Other versions
CA2002106C (fr
Inventor
Richard Allen Partis
Francis Jan Koszyk
Richard August Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of CA2002106A1 publication Critical patent/CA2002106A1/fr
Application granted granted Critical
Publication of CA2002106C publication Critical patent/CA2002106C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002002106A 1988-11-03 1989-11-02 Derives o-acyles du 1,5-dideoxy-1, 5-imino-d-glucitol Expired - Fee Related CA2002106C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26676788A 1988-11-03 1988-11-03
US266,767 1988-11-03
US418,091 1989-10-12
US07/418,091 US5003072A (en) 1988-11-03 1989-10-12 1,5-dideoxy-1,5-imino-D-glucitol derivatives

Publications (2)

Publication Number Publication Date
CA2002106A1 true CA2002106A1 (fr) 1990-05-03
CA2002106C CA2002106C (fr) 1998-12-08

Family

ID=26952022

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002002106A Expired - Fee Related CA2002106C (fr) 1988-11-03 1989-11-02 Derives o-acyles du 1,5-dideoxy-1, 5-imino-d-glucitol

Country Status (9)

Country Link
US (1) US5003072A (fr)
EP (1) EP0367748B1 (fr)
JP (1) JP2907462B2 (fr)
AT (1) ATE117678T1 (fr)
CA (1) CA2002106C (fr)
DE (1) DE68920819T2 (fr)
ES (1) ES2070929T3 (fr)
GR (1) GR3015931T3 (fr)
MX (1) MX9203547A (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US5310745A (en) * 1988-11-03 1994-05-10 G. D. Searle & Co. Antiviral compounds
DE4009561A1 (de) * 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5273981A (en) * 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
EP0566557B1 (fr) * 1992-04-01 1996-09-04 G.D. SEARLE & COMPANY Dérivés substitués aux positions 2- et 3- des 1,5-iminosucres comme médicaments antiviraux
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
JP2001522833A (ja) 1997-11-10 2001-11-20 ジー・ディー・サール・アンド・カンパニー 多剤耐性を治療するためのアルキル化イミノ糖類の使用
AU761748B2 (en) * 1997-12-11 2003-06-12 Chancellor, Masters And Scholars Of The University Of Oxford, The Inhibition of membrane-associated viral replication
EA004705B1 (ru) * 1998-02-12 2004-06-24 Дж.Д.Серл Энд Ко. Применение n-замещенных 1,5-дидезокси-1,5-имино-d-глюцитных производных для лечения инфекций, вызываемых вирусами гепатита
EP1714676A3 (fr) * 1998-02-12 2006-11-15 G.D. Searle LLC. Utilisation de composés 1,5-didesoxy-1,5-imino-D-glucitol N-substitutés pour traiter des infections par un virus de l'hépatite
AR019532A1 (es) * 1998-02-12 2002-02-27 Searle Llc COMPOSICIoN FARMACÉUTICA DEL COMPUESTO 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-SUSTITUIDO
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
ES2311921T3 (es) * 1999-02-12 2009-02-16 United Therapeutics Corporation N-(8,8,8-trifluorooctil)1-5,-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis.
WO2001008672A2 (fr) 1999-02-12 2001-02-08 G.D. Searle & Co. Composes glucamine destines au traitement d'infections dues au virus de l'hepatite
GB0100889D0 (en) 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
WO2001060366A1 (fr) * 2000-02-14 2001-08-23 Pharmacia Corporation Utilisation de composes 1,5-didesoxy-1,5-imino-d-glucitol n-substitues pour le traitement des infections par un virus d'hepatite
ES2393331T3 (es) * 2002-07-17 2012-12-20 Actelion Pharmaceuticals Ltd. Derivados de piperidintriol como inhibidores de la glucosiliceramida sintasa
AU2003248960B2 (en) * 2002-07-17 2009-06-25 Idorsia Pharmaceuticals Ltd Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
GB0313678D0 (en) * 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compounds
GB0313677D0 (en) * 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compound
US20060293250A1 (en) * 2005-06-08 2006-12-28 Michael Major Crystalline sugar compositions and method of making
PL2027137T3 (pl) * 2005-06-08 2015-08-31 Amicus Therapeutics Inc Oczyszczanie imino- i aminocukrów
JP2008545800A (ja) * 2005-06-08 2008-12-18 アミカス セラピューティックス インコーポレイテッド トリフラート化化合物の安定化
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
ITMI20122090A1 (it) 2012-12-06 2014-06-07 Dipharma Francis Srl Sintesi di un inibitore delle glicosiltransferasi
ITMI20130083A1 (it) 2013-01-22 2014-07-23 Dipharma Francis Srl Imminozucchero in forma cristallina
RU2678085C2 (ru) * 2014-07-21 2019-01-23 ДИФАРМА ФРАНЦИС С.р.л. Иминосахар в кристаллической форме
ITUB20150176A1 (it) 2015-04-17 2016-10-17 Dipharma Francis Srl Sintesi di un azazucchero e i suoi intermedi
WO2021116487A1 (fr) 2019-12-13 2021-06-17 Som Innovation Biotech, S.A. Composés destinés à être utilisés dans le traitement d'une maladie de niemann-pick de type c
WO2026143071A1 (fr) * 2024-12-23 2026-07-02 Zevra Therapeutics, Inc. Promédicaments de miglustat pour le traitement de maladies métaboliques neurodégénératives
WO2026143073A1 (fr) * 2024-12-23 2026-07-02 Zevra Therapeutics, Inc. Conjugués de miglustat et d'arimoclomol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2942365A1 (de) * 1979-10-19 1981-05-14 Bayer Ag, 5090 Leverkusen 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO1987003903A1 (fr) * 1985-12-23 1987-07-02 Fred Hutchinson Cancer Research Center Regulation de la replication, de l'infection et de la pathogenese retrovirales
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus

Also Published As

Publication number Publication date
JPH02172975A (ja) 1990-07-04
GR3015931T3 (en) 1995-07-31
CA2002106C (fr) 1998-12-08
MX9203547A (es) 1992-09-01
US5003072A (en) 1991-03-26
ATE117678T1 (de) 1995-02-15
ES2070929T3 (es) 1995-06-16
DE68920819T2 (de) 1995-08-17
EP0367748A3 (fr) 1991-05-08
EP0367748B1 (fr) 1995-01-25
EP0367748A2 (fr) 1990-05-09
JP2907462B2 (ja) 1999-06-21
DE68920819D1 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
EP0367748A3 (fr) Composés antiviraux
DE3273474D1 (en) Synergistic mixture of low and high molecular weight polyalkyl piperidines
NZ211599A (en) 4-piperidinyl amide derivatives and pharmaceutical compositions
AR242184A1 (es) Procedimiento para la preparacion de derivados de n-((alfa-fenil-1-(fenilalquil))piperidinmetanol.
NZ225398A (en) Oxadiazole derivatives and pharmaceutical compositions
NZ223314A (en) N-heterocyclic-n-(4-piperidyl)amides and pharmaceutical compositions
GR3006275T3 (fr)
AU7194687A (en) Anti-dementia agents
CA2059063A1 (fr) Nouveaux composes antiviraux
JPS6419066A (en) Dihydropyridineamides
IL86933A (en) Method and therapeutic compositions for the prevention of fibrin deposition for adhesions
NZ225303A (en) 2,5 dialkyl-3-phenyl piperidine derivatives and pharmaceutical compositions
IL87586A (en) 3(-demethoxypipo- dophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
EP0177965A3 (en) Novel oxa- and thiadiazolyl derivatives and their use
AU564069B2 (en) 1,4-dihydropyridine derivatives containing mmono-or di-saccharide substitutents
GB2206590B (en) Polymer stabilising compositions
IL86437A (en) Pharmaceutical compositions containing nedocromil and derivatives thereof
HU9202873D0 (en) 1,4-dihydropyridine derivatives of paf-antagonistic effect
HUT50329A (en) Process for producing 4-piperidinylmethyl derivatives of 2,3-dihydro-1h-isoindole and of 2,3,4,5-tetrahydro-1h-benzazepines and pharmaceutical compositions
AU2594788A (en) Compositions for the production of magnets and magnets produced therefrom
IT1219570B (it) Procedimento per la desolforazione chimico-biologica del carbone
AU1197388A (en) Treatment of rheumatoid arthritis with 3, 5-dichloromethotrexate
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
SG45354A1 (en) Incorporation of desired groups into polymers the polymers so produced and compositions containing them
ZA884739B (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20071102